BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

644 related articles for article (PubMed ID: 18427756)

  • 1. Radiotherapy of liver metastases. Comparison of target volumes and dose-volume histograms employing CT- or MRI-based treatment planning.
    Pech M; Mohnike K; Wieners G; Bialek E; Dudeck O; Seidensticker M; Peters N; Wust P; Gademann G; Ricke J
    Strahlenther Onkol; 2008 May; 184(5):256-61. PubMed ID: 18427756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomography-guided high-dose-rate brachytherapy.
    Ricke J; Mohnike K; Pech M; Seidensticker M; Rühl R; Wieners G; Gaffke G; Kropf S; Felix R; Wust P
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):479-85. PubMed ID: 20304566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy.
    Dimopoulos JC; Lang S; Kirisits C; Fidarova EF; Berger D; Georg P; Dörr W; Pötter R
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):56-63. PubMed ID: 19289267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of macroscopic pathology measurements with magnetic resonance imaging and assessment of microscopic pathology extension for colorectal liver metastases.
    Méndez Romero A; Verheij J; Dwarkasing RS; Seppenwoolde Y; Redekop WK; Zondervan PE; Nowak PJ; Ijzermans JN; Levendag PC; Heijmen BJ; Verhoef C
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):159-66. PubMed ID: 21183292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton therapy of uveal melanomas: intercomparison of MRI-based and conventional treatment planning.
    Marnitz S; Cordini D; Bendl R; Lemke AJ; Heufelder J; Simiantonakis I; Kluge H; Bechrakis NE; Foerster MH; Hinkelbein W
    Strahlenther Onkol; 2006 Jul; 182(7):395-9. PubMed ID: 16826358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.
    Pötter R; Dimopoulos J; Georg P; Lang S; Waldhäusl C; Wachter-Gerstner N; Weitmann H; Reinthaller A; Knocke TH; Wachter S; Kirisits C
    Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot study in the treatment of endometrial carcinoma with 3D image-based high-dose-rate brachytherapy using modified Heyman packing: clinical experience and dose-volume histogram analysis.
    Weitmann HD; Pötter R; Waldhäusl C; Nechvile E; Kirisits C; Knocke TH
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):468-78. PubMed ID: 15890589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo assessment of the tolerance dose of small liver volumes after single-fraction HDR irradiation.
    Ricke J; Seidensticker M; Lüdemann L; Pech M; Wieners G; Hengst S; Mohnike K; Cho CH; Lopez Hänninen E; Al-Abadi H; Felix R; Wust P
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):776-84. PubMed ID: 15936559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unresectable colorectal liver metastases: percutaneous ablation using CT-guided high-dose-rate brachytherapy (CT-HDBRT).
    Collettini F; Lutter A; Schnapauff D; Hildebrandt B; Puhl G; Denecke T; Wust P; Gebauer B
    Rofo; 2014 Jun; 186(6):606-12. PubMed ID: 24407711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver lesion detection and characterization in patients with colorectal cancer: a comparison of low radiation dose non-enhanced PET/CT, contrast-enhanced PET/CT, and liver MRI.
    Cantwell CP; Setty BN; Holalkere N; Sahani DV; Fischman AJ; Blake MA
    J Comput Assist Tomogr; 2008; 32(5):738-44. PubMed ID: 18830103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CT-guided interstitial brachytherapy of primary and secondary lung malignancies: results of a prospective phase II trial.
    Peters N; Wieners G; Pech M; Hengst S; Rühl R; Streitparth F; Lopez Hänninen E; Felix R; Wust P; Ricke J
    Strahlenther Onkol; 2008 Jun; 184(6):296-301. PubMed ID: 18535804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer.
    Lindegaard JC; Tanderup K; Nielsen SK; Haack S; Gelineck J
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):756-64. PubMed ID: 18191335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT-guided brachytherapy (CTGB) versus interstitial laser ablation (ILT) of colorectal liver metastases: an intraindividual matched-pair analysis.
    Pech M; Wieners G; Kryza R; Dudeck O; Seidensticker M; Mohnike K; Redlich U; Rühl R; Wust P; Gademann G; Ricke J
    Strahlenther Onkol; 2008 Jun; 184(6):302-6. PubMed ID: 18535805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Image fusion of CT and MRI data enables improved target volume definition in 3D-brachytherapy treatment planning.
    Krempien RC; Daeuber S; Hensley FW; Wannenmacher M; Harms W
    Brachytherapy; 2003; 2(3):164-71. PubMed ID: 15062139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Abdominal and pelvic segmented T1-weighted echo-planar imaging and MRI. Comparison with T1-TSE and T2-UTSE sequences].
    Maubon A; Berger V; Aubas P; Ferru JM; Rouanet JP
    J Radiol; 1999 Mar; 80(3):291-6. PubMed ID: 10327336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of contrast-enhanced fluid-attenuated inversion-recovery MRI for intracranial tumors in comparison with post-contrast T1W spin-echo MRI.
    Zhou ZR; Shen TZ; Chen XR; Peng WJ
    Chin Med J (Engl); 2006 Mar; 119(6):467-73. PubMed ID: 16584644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos.
    Seitz K; Strobel D; Bernatik T; Blank W; Friedrich-Rust M; Herbay Av; Dietrich CF; Strunk H; Kratzer W; Schuler A
    Ultraschall Med; 2009 Aug; 30(4):383-9. PubMed ID: 19688670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delineation of target volume for radiotherapy of high-grade gliomas by 99m Tc-MIBI SPECT and MRI fusion.
    Krengli M; Loi G; Sacchetti G; Manfredda I; Gambaro G; Brambilla M; Carriero A; Inglese E
    Strahlenther Onkol; 2007 Dec; 183(12):689-94. PubMed ID: 18040614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer.
    Kirisits C; Pötter R; Lang S; Dimopoulos J; Wachter-Gerstner N; Georg D
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):901-11. PubMed ID: 15936576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-interval T2-weighted subtraction magnetic resonance imaging: a powerful new outcome measure in multiple sclerosis trials.
    Moraal B; van den Elskamp IJ; Knol DL; Uitdehaag BM; Geurts JJ; Vrenken H; Pouwels PJ; van Schijndel RA; Meier DS; Guttmann CR; Barkhof F
    Ann Neurol; 2010 May; 67(5):667-75. PubMed ID: 20437564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.